Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Atypical Pneumonia

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Indian Council of Medical Research's network of pulmonary fibrosis (INPF): A big step forward towards understanding interstitial lung diseases in India.

Lung India : official organ of Indian Chest Society·2026

Same author

A young male with dyspnoea after placement of a pleural drain.

The National medical journal of India·2026

Same author

Phenotyping and unmet need assessment for biological agents in uncontrolled asthma.

Lung India : official organ of Indian Chest Society·2026

Same author

Clinical spectrum and profile of interstitial lung disease: an ambispective study from a tertiary center in North India.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2026

Same author

An intriguing case of central airway obstruction: a diagnostic challenge.

Breathe (Sheffield, England)·2026

Same author

Development and validation of the Hypersensitivity Pneumonitis South Asian Questionnaire for Exposure (HP-SAQE): a novel, qualitative and quantitative tool.

Thorax·2026

Search research articles

Related Experiment Video

Updated: Jun 6, 2026

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

Published on: December 15, 2014

Lipoid pneumonia: an overview.

Vijay Hadda¹, Gopi C Khilnani

¹Department of Medicine, All India Institute of Medical Sciences, New Delhi, 110029 India.

Expert Review of Respiratory Medicine

|December 7, 2010

Summary

This summary is machine-generated.

Lipoid pneumonia, caused by lipids in the lungs, presents with vague symptoms and mimics other lung diseases. Diagnosis requires identifying lipid-laden macrophages in respiratory samples.

More Related Videos

The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice

The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice

Published on: April 2, 2014

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation

Published on: July 6, 2019

Related Experiment Videos

Last Updated: Jun 6, 2026

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

Published on: December 15, 2014

The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice

The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice

Published on: April 2, 2014

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation

Published on: July 6, 2019

Area of Science:

Pulmonology
Pathology

Background:

Lipoid pneumonia is an uncommon lung disease characterized by lipid accumulation in the alveoli.
It is classified into exogenous and endogenous types based on the lipid source.

Purpose of the Study:

To review the clinical, radiological, and pathological features of lipoid pneumonia.
To emphasize diagnostic challenges and confirm diagnostic methods.

Main Methods:

Literature review of lipoid pneumonia cases.
Analysis of clinical presentations, imaging findings, and pathological characteristics.
Discussion of diagnostic confirmation through lipid-laden macrophages.

Main Results:

Lipoid pneumonia presents insidiously with nonspecific respiratory symptoms like dyspnea and cough.
Radiological findings include airspace consolidations, ground-glass attenuation, nodules, and 'crazy-paving' patterns, often mimicking other lung diseases.
Pathology reveals a chronic foreign body reaction with lipid-laden macrophages.

Conclusions:

Diagnosis of lipoid pneumonia is challenging due to nonspecific clinical and radiological features, often leading to delays.
A high index of suspicion is crucial, with diagnosis confirmed by identifying lipid-laden macrophages in respiratory samples.
Treatment protocols remain poorly defined.